换一批The PAZOREAL noninterventional study to assess effectiveness and safety of pazopanib and everolimus in the changing metastatic renal cell carcinoma treatment landscape.
第一作者：
Peter J,Goebell
第一单位：
Department of Urology, University Erlangen, Erlangen, Germany.
作者：
医学主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 肾细胞(Carcinoma, Renal Cell);无病生存(Disease-Free Survival);女(雌)性(Female);人类(Humans);吲唑类(Indazoles);男(雄)性(Male);中年人(Middle Aged);分子靶向治疗(Molecular Targeted Therapy);肿瘤转移(Neoplasm Metastasis);蛋白激酶抑制剂(Protein Kinase Inhibitors);嘧啶类(Pyrimidines);生活质量(Quality of Life);磺胺类(Sulfonamides);TOR丝氨酸-苏氨酸激酶(TOR Serine-Threonine Kinases);血管内皮生长因子受体1(Vascular Endothelial Growth Factor Receptor-1)
DOI
10.2217/fon-2017-0083
PMID
28523933
发布时间
2021-12-04
- 浏览6
Future oncology (London, England)
1463-1471页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
